Alessandro Lupi

Showing 1-3 of 3 articles

Author Gioel Gabrio Secco

Coronary interventions

Very high-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon

Secco G, Ghione M, Mattesini A, Dall’Ara G, Ghilencea L, Kilickesmez K, De Luca G, Fattori R, Parisi R, Marino P, Lupi A, Foin N, Di Mario C

June 20, 2016 | 10.4244/EIJY15M06_04

Author Alessandro Lupi

Coronary interventions

Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions

Lupi A, Rognoni A, Lazzero M, Rolla R, Pergolini P, Bellomo G, Rossi L, Bongo A, Jaffe A

March 18, 2016 | 10.4244/EIJY14M11_04

Author Andrea Rognoni

Regarding “Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review”

Rognoni A, Santagostino M, Sansa M, Bongo A, Lupi A

September 28, 2012 | 10.4244/EIJV8I5A99

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more

December 3, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: DYNAMIC Trial, S3U registry and much more

November 26, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke